African Journal of Biotechnology Vol. 5 (17), pp. 1566-1571, 4 September 2006
Available online at http://www.academicjournals.org/AJB
ISSN 1684–5315 © 2006 Academic Journals
Full Length Research Paper
Pharmacological justification for the ethnomedicinal
use of Amblygonocarpus andongensis stem bark in
pain relief
F. C. Nwinyi1*, G. A. Ajoku2, S. O. Aniagu1, D. Kubmarawa3, N. Enwerem4, S. Dzarma1 and U.S.
Inyang1
1
Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development
(NIPRD), Idu Industrial Area, P.M.B. 21, Garki, Abuja, Nigeria.
2
Department of Microbiology, Human Virology and Biotechnology, National Institute for Pharmaceutical Research and
Development (NIPRD), Idu Industrial Area, P.M.B. 21, Garki, Abuja, Nigeria.
3
Department of Chemistry, Federal University of Technology, P.M.B. 2076, Yola, Adamawa State, Nigeria.
4
Department of Medicinal Plant Research and Traditional Medicine, National Institute for Pharmaceutical Research and
Development (NIPRD), Idu Industrial Area, P.M.B. 21, Garki, Abuja, Nigeria.
Accepted 6 May, 2006
Amblygonocarpus andongensis (family: Mimosaceae) is ethnomedicinally used in Northern Nigeria for
the relief of pain. The methanolic extract of the plant stem bark was evaluated for anti-nociceptive
activity using acetic acid-induced writhing model and formalin test in mice. Anti-inflammatory property
was tested on egg albumin-induced oedema in rats while agar dilution method was used for
antimicrobial effect. The acute toxicity effect (LD50) was also determined via intraperitoneal route. The
results showed the LD50 value to be 547.7 mg/kg i.p. There was a significant (P < 0.05) dose-dependent
reduction of acetic acid-induced pain at 50, 100, 200 mg/kg i.p. The extract at the same doses
significantly (P < 0.05) inhibited pains in both early and late phases of the formalin test. However, the
extract showed neither anti-inflammatory nor anti-microbial effects. The results corroborate the folkloric
use of the plant.
Key words: Amblygonocarpus andongensis, anti-nociception; anti-inflammation, acute toxicity, antimicrobial
effect.
INTRODUCTION
Amblygonocarpus andongensis (Mimosaceae) is widely
spread in tropical Africa, mostly in the Savannah areas. It
is a tree usually 30–40 feet high, but reaching 60 feet and
5 feet girth in moist areas with a wide flat open crown.
The bole is clean and straight. The bark is grey to brown,
rough, flaking off in irregular patches leaving reddish
scars; slash dark brown, crumbly lighter beneath (Keay et
al., 1964). The leaves are mostly at the ends of the erect
twig and entirely glabrous with leaflets pale-blue-green.
The flowers are white or yellowish and sweetly scented.
The fruits are dark brown, 4–5 inches long by about 1
inch across, hanging on thick stalks 2–3 inches long
(Keay et al., 1964). From the ethnobotanical knowledge
of traditional medicine in Adamawa State, Northern
Nigeria, an infusion of the bark is taken to relieve pains in
the breast. The objective of this study was to establish
the scientific basis on which this claim is made.
MATERIALS AND METHODS
Plant collection and extraction
*Corresponding authors E-mail: soa267@bham.ac.uk. Tel:
+234 802 321 5755.
The stem bark was collected from Adamawa State, Northern
Nigeria in July 2001. The identification of the plant was carried out
at the Forestry Research Institute, Ibadan, Nigeria. The stem bark
Nwinyi et al.
1567
of the plant was air-dried and grounded to powder in a mortar with
the pestle. 375 g of the powdered material was cold macerated in 1
L of methanol at 25°C for 24 h. The sample was then suctionfiltered through Whatman #1 filter paper. The filtrate was then
evaporated to near dryness with a rotary evaporator at 90–100°C to
give a dark brownish crude extract. The crude extract was brought
to complete dryness over water bath and the yield was 1.8% (w/w).
Writhes (%) = (Test mean for every interval/Control mean for the
same interval) x 100
Animals
Also, the percentage dose-effect of the extract on the abdominal
constriction was calculated thus;
Swiss Albino mice (22.1–28.2 g) and Wistar rats (208.3–220.0 g) of
both sexes were used for the studies. The animals were bred in the
Animal Facility Centre (AFC), Department of Pharmacology and
Toxicology, National Institute for Pharmaceutical Research and
Development (NIPRD), Abuja, Nigeria. The animals were
maintained under normal environmental conditions. They were fed
ad libitum with standard feed (Ladokun Feeds PLC, Ibadan,
Nigeria) and water from the Abuja Municipal Area Council except
when starvation was otherwise needed during the investigations.
Chemicals
Glacial acetic acid (Searle, Essex, England), formaldehyde 40% w/v
(M & B, England), triton X-100 (GE Healthcare, UK), nutrient agar
(BBL, USA), nutrient broth (BBL, USA) were used for the studies.
Test organisms
The microorganisms used in this study include Pseudomonas
aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 13709),
Escherichia coli (ATCC 9637), Candida albicans (ATCC 10231),
Klebsiella pneumoniae, Proteus mirabilis, Bacillus subtilis and
Salmonella typhi all of which were clinically isolated, standardized
and stored by the Department of Microbiology, Human Virology and
Biotechnology, National Institute for Pharmaceutical Research and
Development (NIPRD), Abuja, Nigeria.
tion, the number of abdominal constrictions (writhes) made within
the next 5 min by every mouse was counted using a manual table
counter. The percentage of the writhes for every time interval (30,
60, 90, 120 min) was calculated as follows:
Dose-effect (%) = (Total abdominal constrictions per dose/Total
abdominal constrictions for control group) x 100
The difference between 100 and the calculated percent abdominal
constriction is considered to be the dose-pain inhibition effect (%) of
the extract. The values were all compared statistically with the
normal saline control group.
Formalin test
The modified method of Dubuisson and Dennis (1977) was adopted
for this study. Four groups of mice (of five mice each) was given the
extract (50, 100, 200 mg/kg i.p.) and normal saline (10 ml/kg i.p.),
respectively. 30 min post treatment, 50 l of 2.5% formalin was
injected into the sub-plantar surface of the left hind paw of every
mouse. The severity of pain exhibited by every mouse was
observed and rated as scores:
0 = mice walked or stood firmly on the injected paw
1 = partially elevated the paw from the floor
2 = elevated the paw without contact with the floor
3 = licked, bit or shook the paw
These observations were recorded every 2 min for the first 10 min
(early phase) and at every 5 min between the 10 and 60 min
interval (late phase).
Anti-inflammatory study
Acute toxicity study
This involves the estimation of the median lethal dose (LD50), which
is the dose that will kill 50% of the animal population within 24 h
post treatment with the extract. The method of Lorke (1983) was
modified and used. Swiss Albino mice were starved of feed but
allowed access to water 24 h prior to the study and were then
grouped (four mice per group). They were treated intraperitoneally
with different doses of the extract (500, 600, 700, 800, 900, 1000,
1500 mg/kg). The animals were then observed for 24 h for any
behavioural effects such as nervousness, excitement, dullness, incoordination or even death. The LD50 was estimated from the
geometric mean of the dose that caused 100% mortality and the
dose, which caused no lethality at all.
Acetic acid-induced writhing in mice
The study was carried out according to the method of Siegmund et
al. (1957) as modified by Koster et al. (1959). The mice were
grouped into four (of five mice each). Three different groups of mice
were pre-treated with the extract at doses of 50, 100 and 200 mg/kg
i.p., respectively. The fourth group of mice received normal saline
(10 ml/kg i.p.). 10 ml/kg of 0.75 % glacial acetic acid was then
administered intraperitoneally to every mouse 30, 60, 90 and 120
min post extract/normal saline treatment. Each mouse was placed
in a transparent observation box. 5 min post acetic acid administra-
The extract was tested for its ability to inhibit or suppress
inflammation using fresh egg albumin-induced oedema model in
rats. This was in accordance with the technique of Winter et al.
(1962) as modified by Akah and Nwambie (1994). Both male and
female rats used for the investigation were fasted overnight. They
were deprived of water during the experiment to ensure uniform
hydration and to minimize variability in edematous response (Winter
et al., 1963). The rats were separated into groups (of five rats each)
and were treated with the extract (25, 50, 100 mg/kg i.p.) and
normal saline (10 ml/kg i.p.), respectively. 30 min post treatment,
inflammation was induced by injecting 0.1 ml of fresh egg albumin
(phlogistic agent) into the sub-plantar surface of the right hind paw
of the rats. The measurement of the paw volume (cm3) was done
on the principle of volume displacement using LETICA Digital
Plethysmometer (LE 7500) which was earlier calibrated with 0.1 %
Triton X-100. The readings were taken before and at 20 min
intervals after the injection of egg albumin for a period of 2 h. The
oedema at every interval was calculated in relation to the paw
volume before the injection of the phlogogen.
Antimicrobial activity
The agar dilution method of Jonas et al. (1989) was employed to
determine the antimicrobial activity. Nutrient agar was prepared
according to the manufacturer’s instruction while the extract (4 mg)
1568
Afr. J. Biotechnol.
% Inhibition
100
90
Pain inhibition (%)
80
*
*
*
70
60
50
40
30
20
10
0
Control
50
100
200
Dose (mg/kg i.p.)
* P < 0.05
Figure 1. The dose-pain inhibition effects of A. andongensis stem bark on glacial acetic acid-induced
abdominal constriction in mice.
was dissolved in 1 ml of sterile distilled water to give an extract
concentration of 4 mg/ml. The later solution was then diluted with
19 ml of the prepared nutrient agar to provide a required
concentration of 2000 g/ml. Each of the test organisms was
cultured overnight in nutrient broth to approximately 5 X 107 to 9 X
107 cfu/ml. A 1:20 dilution of the later was then made in normal
saline for inoculation. Surface streaking of each innoculum was
done on the extract-containing nutrient agar plate using a wire loop
with a capacity of 0.002 ml. The organisms were also streaked on
plates containing only nutrient agar (organism viability control) and
on plates containing nutrient agar and sterile distilled water, which
also served as the control. The plates were kept overnight in an
incubator at 37°C. They were then observed for microbial growth
inhibition.
doses and at every interval. The dose-pain reduction
effect of the extract was calculated to be 80.3, 82.0 and
86.7% for the 50, 100 and 200 mg/kg i.p groups,
respectively. This shows a dose-dependent reduction of
acetic acid-induced pain (Figure 1). The study revealed
anti-nociceptive effect of the extract from the period of 30
to 120 min. However, the maximal anti-nociceptive
effects for 100 and 200 mg/kg i.p doses were seen at the
60 min having writhing of 5.22 and 0.00 % (i.e. percent
inhibition of writhes of 94.8 and 100.0 %), respectively
(Figure 2). The values were all significantly (P < 0.05)
different from the control.
Statistical analysis
Formalin test
All the results were expressed as mean ± SEM. The significance of
difference between the control and treated groups were determined
using two-way analysis of variance (ANOVA), followed by Student ttest. P-values < 0.05 were considered to be statistically significant.
The study revealed that the stem bark extract of A.
andongensis had a significant (P < 0.05) activity in both
the early (0–10 min) and late (15–60 min) phases of the
formalin test. In the early phase, the activities were seen
to be higher with decreasing doses. In this phase, the
doses of 200, 100 and 50 mg/kg i.p showed a mean
severity of pain of 4.8 ± 2.9, 4.3 ± 0.9 and 2.5 ± 1.0,
respectively. In the late phase however, the activity was
least with the lowest dose of 50 mg/kg showing mean
severity of pain of 12.8 ± 5.4 as against 7.8 ± 2.9 and 8.3
± 2.3 for 100 and 200 mg/kg i.p doses, respectively. All
the values were significant (P < 0.05) compared with the
control (Table 1).
RESULTS
Acute toxicity study
All the mice became dull within 10–15 min post extract
administration. However, only mice treated with doses
600 mg/kg i.p died within 24 h of treatment. The median
lethal dose (LD50) was estimated to be 547.7 mg/kg i.p.
Acetic acid-induced writhing in mice
The stem bark extract of A. andongensis (50, 100, 200
mg/kg i.p.) significantly (P < 0.05) reduced the degree of
acetic acid-induced abdominal constrictions in mice at all
Anti-inflammatory study
The stem barks extract of A. andongensis (25, 50, 100
mg/kg i.p.) did not suppress or inhibit fresh egg albumin-
Nwinyi et al.
Control
Ext. 50 mg/kg
Ext. 100 mg/kg
1569
Ext. 200 mg/kg
120
% Writhing reflex
100
80
60
40
20
0
30
60
90
120
Time (min)
Figure 2. The time effect of methanolic extract of A. andongensis stem bark on glacial acetic acid-induced
abdominal constriction in mice.
Table 1. Effect of methanolic extract of A. andongensis stem bark on early and late phases of formalin-induced pain in mice.
Treatment
Group (n = 5)
Early Phase
Late Phase
Score of pain ± SEM
% Inhibition
Score of pain ± SEM
% Inhibition
Normal saline (10 ml/kg i.p.)
11.00 ± 1.0
-
18.75 ± 3.2
-
A. andongensis (Mg/kg i.p.)
50
100
200
2.50 ± 1.0***
4.25 ± 0.9***
4.75 ± 2.9*
77.27
61.36
56.82
12.75 ± 5.4
7.75 ± 2.9
8.25 ± 2.3
32.00**
58.67*
56.00***
Student t-test, *P < 0.05, **P < 0.01, ***P < 0.005 vs normal saline group.
induced inflammation in rats (P > 0.05). The statistical
comparison was done with the normal saline treated rats
(Figure 3).
Antimicrobial activity
The methanolic extract (2000 g/ml) did not show
antimicrobial activity against in all the test organisms
used in the study.
DISCUSSION
The present study revealed some of the pharmacological
basis for the ethnomedicinal use of stem bark of A.
andongensis in pain relief. Acetic acid-induced abdominal
constriction model adopted for anti-nociceptive study is a
sensitive method in detecting analgesic effect of
medicinal agents. It is able to detect anti-nociceptive
effect of compounds/dose levels that may be inactive in
other methods like the tail-flick test (Collier et al., 1968;
Bentley et al., 1981). The mechanism for the abdominal
constriction is postulated to partly involve local peritoneal
receptors (Bentley et al., 1983) caused by peritoneal fluid
concentration of PGE2 and PGF2 (Deraedt et al., 1980).
The extract showed a significant dose-dependent
reduction in the number of acetic acid-induced writhes in
mice. This probably means that the extract is able to
reduce the receptor sensitivity to the chemically (acetic
acid)-induced pain in a dose-dependent manner. This
therefore shows anti-nociceptive activity.
This result was further corroborated by the formalin test
results. According to Dubuisson and Dennis (1977) and
Tjølsen et al. (1992), the nociception induced by formalin
occurs in two distinct phases. The early phase represents
the phasic pain while the late phase represents the tonic
pain. The first phase ensues immediately after formalin
injection and continues for 5 min, after which nociception
1570
Afr. J. Biotechnol.
Control
Ext. 25 mg/kg
Ext. 50 mg/kg
Ext. 100 mg/kg
1.6
Average oedema (cm3)
1.4
1.2
1
0.8
0.6
0.4
0.2
0
0
20
40
60
80
100
120
Time (min)
Figure 3. Effect of methanolic extract of A. andongensis stem bark on egg albumin-induced paw oedema in rats.
appears to diminish. In the second phase, nociception
returns to high levels beginning 15–20 min after formalin
injection and continuing for ~ 60 min. The first phase is
believed to be a direct result of stimulation of nociceptors
in the paw while the second phase may reflect the
inflammation process and at least to some degree, the
sensitization of central nociceptive neurons (Coderre et
al., 1990; Coderre and Melzack, 1992).
The present study revealed that the extract showed
activity on both the early and late phase of nociception.
This did not only support the anti-nociceptive activity of
the extract but also depicted its possible mechanisms of
action. Tjølsen et al. (1992) reported that formalin test
method is useful for elucidating the mechanism of pain
and analgesia. Drugs which act mainly centrally such as
narcotics, inhibit both phases of formalin-induced pain,
while drugs such as aspirin, hydrocortisone and
dexamethasone which are primarily peripherally acting,
only inhibit the late phase (Chen et al., 1995; Elisabetsky
et al., 1995; Santos et al., 1995). The activity of the
extract on both early and late phases of pain therefore
suggests the possible involvement of the central
mechanism in the pain inhibition. Also, the late phase of
formalin test involves peripheral inflammatory process
and since the extract was able to inhibit this phase
involving inflammation, it might also mean an involvement
of the peripheral mechanism in anti-nociceptive effect.
However, the later assumption of involvement of the
peripheral mechanism may not be true since antiinflammatory study carried out showed that the extract at
the tested doses of 25, 50, 100 mg/kg i.p did not reduce
egg albumin-induced inflammation in rats. This method is
an in vivo model of inflammation used to screen agents
for acute inflammatory effect (Akah et al., 1993; Akah and
Nwambie, 1994; Amos et al., 2002).
Some drugs are known to have clinically effective
analgesic and anti-inflammatory properties. This is well
documented for various non-steroidal anti-inflammatory
drugs (NSAIDs) especially with salicylates and their
congeners (Reuse, 1978; Beuoist and Misse, 1979;
Famaey, 1983). Others are potent anti-inflammatory
agents but lack or have only weak analgesic properties;
such includes phenylbutazone (Insel, 1996). Some are
however effective analgesics, but lack significant antiinflammatory properties, e.g. phenacetin, acetaminophen
(Insel, 1996). The extract therefore belongs to the later
classification since it showed anti-nociceptive activity and
no anti-inflammatory effect.
The intraperitoneal median lethal dose of the extract
estimated to be 547.7 mg/kg probably suggests that the
extract may not have a wide safety margin. Lorke (1983)
considered LD50 values > 1000 mg/kg body weight as
being safe. This therefore means that care needs to be
taken on the frequency and dose of intake of the stem
bark infusion. It is possible that cumulative toxic effects
may occur if the extract is taken over time. Some reports
have shown the need for sub-chronic data in the
prediction of hazards of long term, low dose exposure to
a particular compound (McNamara, 1976). Also worth
noting is the dullness observed in the treated mice in the
acute toxicity study. This probably confirms the suggested central activity mechanism of anti-nociception. The
lack of microbial growth inhibition observed in the antimicrobial study probably shows that the organisms were
Nwinyi et al.
not susceptible to its activity or that the extract does not
have antimicrobial activity at all. However, it is possible
that other microorganisms may be susceptible to the
effects of the plant extract.
In conclusion, these studies have shown that the stem
bark extract of A. andongensis contains some active
principles with the potentials of being good analgesics.
This was demonstrated in its ability to inhibit pain in both
acetic acid-induced writhing and formalin tests. These
results conform to the folkloric use of the plant and also
revealed its potential for the development of putative
herbal analgesic remedies. Efforts are ongoing to
ascertain the long-term toxicity profile of the plant.
ACKNOWLEDGEMENTS
The authors of this paper appreciate the technical
assistance of Victor Agomuo and Hauwa Abdullahi. They
are also grateful to Charles Balogun for the secretarial
work.
REFERENCES
Akah P, Okogun JI, Ekpendu TO (1993). Anti-oedema and analgesic
activity of Diodia scandans extract in rats and mice. Phytotherapy
Research 7, 317–319.
Akah P, Nwambie AI (1994). Evaluation of Nigerian traditional
medicines: Plants used for rheumatic disorder. J. Ethnopharmacol.
42, 179–182.
Amos S, Chindo B, Edmond I, Akah P, Wambebe C, Gamaniel K
(2002). Anti-inflammatory and anti-nociceptive effects of Ficus
platyphylla in rats and mice. J. Herbs Spices Medicinal Plants 9, 47–
53.
Bentley GA, Newton SH, Starr J (1981). Evidence for an action of
morphine and enkephalins on sensory nerve endings in the mouse
peritoneum. Brit. J. Pharmacol. 73, 325–332.
Bentley GA, Newton SH, Starr J (1983). Studies on the anti-nociceptive
action of
-agonist drugs and their interaction with opioid
mechanisms. Bri. J. Pharmacol. 79, 125–134.
Beuoist JM, Misse JL (1979). In: Giroud JP, Mathe G, Meyniel G (Eds.),
Pharmacologic clinique: Bases de la therapeutique 2. Expansion
Scientifique Francaise, Paris. pp. 1049– 1091.
Chen YF, Tsai HY, Wu TS (1995). Anti-inflammatory and analgesic
activity from roots of Angelica pubescens. Planta Medica 61, 2–8.
Coderre TJ, Vacarino AL, Melzack R (1990). Central nervous system
plasticity in the tonic pain response to subcutaneous formalin
injection. Brain Res. 535: 155–158.
Coderre TJ, Melzack R (1992). The contribution of excitatory amino
acids to central sensitization and persistent nociception after
formalin-induced tissue injury. J. Neurosci. 12: 3665–3670.
Collier HOJ, Dinneen LC, Johnson CA, Schneider C (1968). The
abdominal constriction response and its suppression by analgesic
drugs in the mouse. Brit. J. Pharmacol. 32, 295–310.
View publication stats
1571
Deraedt R, Jougney S, Falhout M (1980). Release of prostaglandin E
and F in an algogenic reaction and its inhibitions. Europ. J.
Pharmacol. 51: 17–24.
Dubuisson D, Dennis SG (1977). The formalin test: a quantitative study
of the analgesic effects of morphine, meperidine and brain stem
stimulation in rats and cats. Pain 4, 161–174.
Elizabetsky E, Amadar TA, Albuquergue RR, Nunes DS, Carvalho ADC
(1995). Analgesic activity of Psychotria colorata (Willd. ex R & S)
Muell. Arg. Alkaloids. J. Ethnopharmacol. 48, 77–83.
Famaey JP (1983). In: Blotman F, Crastes de Paulet A, Simon L (Eds),
Biochimie de inflammation. Acide Arachidoniqueet ses Derives.
Mason, Paris, pp. 174–188.
Insel PA (1996). In: Alfred GG, Hardman JG, Limbird LE, Molinöff PB,
Ruddon RW (Eds.), Analgesic – anti-pyretic and anti-inflammatory
agents and drugs employed in the treatment of gout: The
Pharmacological Basis of Therapeutics. McGraw Hill, New York pp.
617–657.
Jonas RN, Gavan C, Thornberry C, Fuchs PC, Gerlach EH, Knapp JS,
Murray P, Washington HJA (1989). Standardization of disk diffusion
and agar dilution susceptibility test for Neissaria gonorrhoea;
Interpretative criteria and quality control guidance for ceftriaxone,
penicillin, spectinomycin and tetracycline. J. Clinical Microbiol. 27,
2758 – 2766.
Keay RWJ, Onochie CFC, Stanfield DP (1964). Nigerian trees. Volume
II. Nigerian National Press Ltd. Apapa, Lagos. pp. 78–106.
Koster R, Anderson N, Debber EJ (1959). Acetic acid for analgesic
screening. Federation Proceedings 18: 412.
Lorke D (1983). A new approach to acute toxicity testing. Archives of
Toxicology 54: 275–287.
McNamara BP (1976). Concepts in health evaluation of commercial and
industrial chemicals. In: New concepts in safety evaluation.
Hemisphere, Washington DC pp. 61–140.
Reuse J (1978). In: Fabre J (Ed.) Therapeutique Medicale. Flammarion
Medicine–Sciences, Paris. pp. 207–219.
Santos ARS, Filho VC, Niero R, Yunes RA, Calixto JB (1995). Analysis
of the mechanisms underlying the anti-nociceptive effect of the
extract of plants from the Genus phyllantus. Gen. Pharmacol. 26 (7),
1499–1506.
Siegmund EA, Cadmus, RA, Lu G (1957). Screening of analgesic
including aspirin type compound based upon the antagonism of
chemically induced writhing in mice. J. Pharmacol. Experimental
Therapeutics 119, 184–186.
Tjølsen A, Berge OG, Hunstaar S, Rosland JH, Hole K (1992). The
formalin test: An evaluation of the method. Pain 51, 5–17.
Winter EA, Risely EA, Nuss GV (1962). Carageenin-induced oedema in
hind paw of rats as an assay for anti-inflammatory drug. Proc. Soc.
Exp. Biol. Med. 111, 544–547.
Winter EA, Risely EA, Nuss GV (1963). Anti-inflammatory and antipyretic activities of Indomethacin. J. Pharmacol. Experimental
Therapeutics 141: 369–376.